NCS1 and breast carcinoma: In this study, we report for the first time that NCS‐1 is more highly expressed in the basal molecular subtype, a subtype which has a strong overlap with TNBC and is associated with poorer survival rates in breast cancer patients (Prat et al., 2015; Rivenbark et al., 2013; Sorlie et al., 2003).